lncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer

Figure 5

A nomogram based on CDKN2B-AS1 expression and clinical stage. (a) Construction of a nomogram for predicting PFI. Calibration curve of (b) 1 year, (c) 3 years, and (d) 5 years.

(a)

(b)

(c)

(d)